“…For example, the full inclusion of PA is not uncommon in patients with a tendency to progressive dilatation of the implanted conduit or those with poorly controlled blood pressures that may be too high and disabling for the PA [ 1 – 6 , 8 , 40 , 43 , 57 ]. However, these patients who exhibit disorders of the connective tissue structure can potentially have a reduced benefit from use by the Ross procedure because once the PA is encased in the rigid dacron prosthesis, its mobility is greatly reduced with a detrimental effect on the function of the PA as a living tissue [ 18 – 20 , 60 ]. For these recipients of the Ross procedure, although not ideal candidates and for whom the use of PA is not discouraged, implant failure may occur, as shown with the reoperation rate ranging from 20% to 50%—still considered low—and between 1% and 2% per patient-year [ 37 , 41 , 49 ].…”